Nexus Pharmaceuticals
Dana Gebel is an accomplished professional in the pharmaceutical industry, currently serving as a Senior Manager in Alliance Management at Nexus Pharmaceuticals since July 2019. Prior roles include Senior Project Manager and Project Manager in Technical Transfer at Nexus Pharmaceuticals, as well as Technology Transfer Leader and Specialist at Fresenius Kabi USA from August 2015 to July 2019. Dana's academic background includes a Master’s degree in Pharmacology and a Master’s degree in Business Administration and Management from Loyola University Chicago, along with a Bachelor's degree in Chemistry from the same institution. Dana also contributed to research as an Undergraduate Researcher at Loyola University Chicago, where experiments focused on chemical reaction dynamics, resulting in co-authorship of a publication in the Journal of Vacuum Science & Technology A.
This person is not in the org chart
Nexus Pharmaceuticals
Nexus Pharmaceuticals is a US-based, family-owned, minority-owned healthcare company and proud diverse supplier. We specialize in innovative processes to make difficult-to-manufacture specialty drugs that are easier to use, less labor-intensive, and more streamlined in practice. Nexus ensures that its high-quality, FDA-approved drugs fulfill a critical, unmet medical need and delivers dependable life-saving treatment options when and where they’re needed most. We are in the process of building Project Tomorrow – a state-of-the-art manufacturing facility in Pleasant Prairie, Wisconsin and only project of its kind in the last 30 years. Read about our commitment to Wisconsin and see our progress at nexuspharma.net/project-tomorrow